1. Home
  2. ECOR vs KOSS Comparison

ECOR vs KOSS Comparison

Compare ECOR & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • KOSS
  • Stock Information
  • Founded
  • ECOR 2005
  • KOSS 1953
  • Country
  • ECOR United States
  • KOSS United States
  • Employees
  • ECOR N/A
  • KOSS N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KOSS Consumer Electronics/Appliances
  • Sector
  • ECOR Health Care
  • KOSS Consumer Staples
  • Exchange
  • ECOR Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • ECOR 65.0M
  • KOSS 68.4M
  • IPO Year
  • ECOR 2018
  • KOSS N/A
  • Fundamental
  • Price
  • ECOR $16.49
  • KOSS $7.74
  • Analyst Decision
  • ECOR Strong Buy
  • KOSS
  • Analyst Count
  • ECOR 1
  • KOSS 0
  • Target Price
  • ECOR $15.00
  • KOSS N/A
  • AVG Volume (30 Days)
  • ECOR 97.7K
  • KOSS 188.7K
  • Earning Date
  • ECOR 11-13-2024
  • KOSS 01-30-2025
  • Dividend Yield
  • ECOR N/A
  • KOSS N/A
  • EPS Growth
  • ECOR N/A
  • KOSS N/A
  • EPS
  • ECOR N/A
  • KOSS N/A
  • Revenue
  • ECOR $23,327,000.00
  • KOSS $12,092,999.00
  • Revenue This Year
  • ECOR $61.40
  • KOSS N/A
  • Revenue Next Year
  • ECOR $38.43
  • KOSS N/A
  • P/E Ratio
  • ECOR N/A
  • KOSS N/A
  • Revenue Growth
  • ECOR 74.10
  • KOSS N/A
  • 52 Week Low
  • ECOR $5.25
  • KOSS $2.27
  • 52 Week High
  • ECOR $15.25
  • KOSS $18.73
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 69.93
  • KOSS 58.64
  • Support Level
  • ECOR $13.22
  • KOSS $7.13
  • Resistance Level
  • ECOR $14.87
  • KOSS $7.88
  • Average True Range (ATR)
  • ECOR 1.34
  • KOSS 0.37
  • MACD
  • ECOR 0.30
  • KOSS 0.06
  • Stochastic Oscillator
  • ECOR 87.04
  • KOSS 86.32

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: